Non-hodgkin lymphoma articles within Scientific Reports

Featured

• Article
  26 April 2024 | Open Access

  Hyper-N-glycosylated SEL1L3 as auto-antigenic B-cell receptor target of primary vitreoretinal lymphomas

  • Michelle Elbert
  • , Frank Neumann
  •  & Moritz Bewarder

• Article
  05 April 2024 | Open Access

  Prognostic value of the combination of volume, massiveness and fragmentation parameters measured on baseline FDG pet in high-burden follicular lymphoma

  • S. Draye-Carbonnier
  • , V. Camus
  •  & P. Decazes

• Article
  19 March 2024 | Open Access

  B-cell receptor signaling activity identifies patients with mantle cell lymphoma at higher risk of progression

  • Simona Gambino
  • , Francesca Maria Quaglia
  •  & Maria Teresa Scupoli

• Article
  14 March 2024 | Open Access

  Prognostic mutation signature would serve as a potential prognostic predictor in patients with diffuse large B-cell lymphoma

  • Shih-Feng Cho
  • , Tsung-Jang Yeh
  •  & Sin-Hua Moi

• Article
  04 November 2023 | Open Access

  Comparison of the prognostic impact of IPI and PIT in peripheral T-cell lymphoma in real-world practice with a large elderly population

  • Nobuhiko Nakamura
  • , Nobuhiro Kanemura
  •  & Masahito Shimizu

• Article
  29 October 2023 | Open Access

  The synergy of the XPO1 inhibitors combined with the BET inhibitor INCB057643 in high-grade B-cell lymphoma via downregulation of MYC expression

  • Manman Deng
  • , Jinshui Tan
  •  & Bing Xu

• Article
  28 September 2023 | Open Access

  Epigenetic profiles of elevated cell free circulating H3.1 nucleosomes as potential biomarkers for non-Hodgkin lymphoma

  • Priscilla Van den Ackerveken
  • , Alison Lobbens
  •  & Marielle Herzog

• Article
  22 August 2023 | Open Access

  Prognostic value of post-treatment serum soluble interleukin-2 receptor in newly diagnosed diffuse large B-cell lymphoma patients who achieved complete metabolic response following R-CHOP therapy

  • Yuko Shirouchi
  • , Noriko Nishimura
  •  & Dai Maruyama

• Article
  12 August 2023 | Open Access

  An artificial intelligence method using FDG PET to predict treatment outcome in diffuse large B cell lymphoma patients

  • Maria C. Ferrández
  • , Sandeep S. V. Golla
  •  & Ronald Boellaard

• Article
  23 March 2023 | Open Access

  MRI-based long-term follow-up of indolent orbital lymphomas after curative radiotherapy: imaging remission criteria and volumetric regression kinetics

  • Christian Hoffmann
  • , Christopher Mohr
  •  & Maja Guberina

• Article
  04 November 2022 | Open Access

  T-cell counts in peripheral blood at leukapheresis predict responses to subsequent CAR-T cell therapy

  • Fumiya Wada
  • , Tomoyasu Jo
  •  & Akifumi Takaori-Kondo

• Article
  02 June 2022 | Open Access

  Plasma extracellular vesicles bearing PD-L1, CD40, CD40L or TNF-RII are significantly reduced after treatment of AIDS-NHL

  • Laura E. Martínez
  • , Shelly Lensing
  •  & Marta Epeldegui

• Article
  24 February 2022 | Open Access

  Comprehensive geriatric assessment as a useful tool in predicting adverse events in elderly patients with diffuse large B-cell lymphoma

  • Toshihiro Tanaka
  • , Rika Sakai
  •  & Kazuo Tamura

• Article
  17 February 2022 | Open Access

  Characterization of the canine CD20 as a therapeutic target for comparative passive immunotherapy

  • Joana N. R. Dias
  • , André Almeida
  •  & Frederico Aires-da-Silva

• Article
  02 February 2022 | Open Access

  Immune-related adverse events in the treatment of non-Hodgkin lymphoma with immune checkpoint inhibitors

  • Lisa Argnani
  • , Beatrice Casadei
  •  & Pier Luigi Zinzani

• Article
  17 January 2022 | Open Access

  Mutated RAS-associating proteins and ERK activation in relapse/refractory diffuse large B cell lymphoma

  • Alexandre Benoit
  • , Elisabeth Bou-Petit
  •  & Koren K. Mann

• Article
  07 January 2022 | Open Access

  The expression and clinical significance of programmed cell death receptor 1 and its ligand in tumor tissues of patients with extranodal nasal NK/T cell lymphoma

  • Yu Feng
  • , Xia Feng
  •  & Caigang Xu

• Article
  10 December 2021 | Open Access

  Electronic case report forms generation from pathology reports by ARGO, automatic record generator for onco-hematology

  • Gian Maria Zaccaria
  • , Vito Colella
  •  & Sabino Ciavarella

• Article
  10 December 2021 | Open Access

  Diagnostic value of baseline ¹⁸FDG PET/CT skeletal textural features in follicular lymphoma

  • Julie Faudemer
  • , Nicolas Aide
  •  & Charline Lasnon

• Article
  08 December 2021 | Open Access

  Characterization of the humoral immune response to the EBV proteome in extranodal NK/T-cell lymphoma

  • Zhiwei Liu
  • , Yomani D. Sarathkumara
  •  & Qing Lan

• Article
  24 November 2021 | Open Access

  Incorporation of next-generation sequencing in clinical practice using solid and liquid biopsy for patients with non-Hodgkin’s lymphoma

  • Mariana Bastos-Oreiro
  • , Julia Suárez-González
  •  & Carolina Martínez-Laperche

• Article
  19 November 2021 | Open Access

  Effectiveness and tolerability of radiotherapy for patients with indolent non-Hodgkin’s lymphoma: a monocenter analysis

  • I. Hadi
  • , A. Schummer
  •  & M. Li

• Article
  27 September 2021 | Open Access

  Detailed characterization of the transcriptome of single B cells in mantle cell lymphoma suggesting a potential use for SOX4

  • Simone Valentin Hansen
  • , Marcus Høy Hansen
  •  & Charlotte Guldborg Nyvold

• Article
  19 February 2021 | Open Access

  Modified conditioning regimen with idarubicin followed by autologous hematopoietic stem cell transplantation for invasive B-cell non-Hodgkin’s lymphoma patients

  • Chen Tian
  • , Yueyang Li
  •  & Yafei Wang

• Article
  17 February 2021 | Open Access

  Spectrum of mutational signatures in T-cell lymphoma reveals a key role for UV radiation in cutaneous T-cell lymphoma

  • Christine L. Jones
  • , Andrea Degasperi
  •  & Sean J. Whittaker

• Article
  05 February 2021 | Open Access

  Efficacy and safety of new anti-CD20 monoclonal antibodies versus rituximab for induction therapy of CD20⁺ B-cell non-Hodgkin lymphomas: a systematic review and meta-analysis

  • Chengxin Luo
  • , Guixian Wu
  •  & Xi Li

• Article
  03 December 2020 | Open Access

  SIRT3, a metabolic target linked to ataxia-telangiectasia mutated (ATM) gene deficiency in diffuse large B-cell lymphoma

  • Kavita Bhalla
  • , Sausan Jaber
  •  & Ronald B. Gartenhaus

• Article
  14 October 2020 | Open Access

  5-aminolevulinic acid-mediated photodynamic therapy can target aggressive adult T cell leukemia/lymphoma resistant to conventional chemotherapy

  • Yasuhisa Sando
  • , Ken-ichi Matsuoka
  •  & Yoshinobu Maeda

• Article
  03 September 2020 | Open Access

  Population-based epidemiological data of follicular lymphoma in Poland: 15 years of observation

  • Anna Szumera-Ciećkiewicz
  • , Urszula Wojciechowska
  •  & Jan Walewski

• Article
  04 August 2020 | Open Access

  Selective dysregulation of ROCK2 activity promotes aberrant transcriptional networks in ABC diffuse large B-cell lymphoma

  • Edd Ricker
  • , Akanksha Verma
  •  & Alessandra B. Pernis

• Article
  23 July 2020 | Open Access

  IL-21 Stimulates the expression and activation of cell cycle regulators and promotes cell proliferation in EBV-positive diffuse large B cell lymphoma

  • Yuxuan Wang
  • , Chengcheng Wang
  •  & Liang Wu

• Article
  15 July 2020 | Open Access

  Prognostic significance of interim PET/CT response for the treatment of advanced-stage marginal zone lymphoma in the post-rituximab era

  • Ga-Young Song
  • , Sang Eun Yoon
  •  & Deok-Hwan Yang

• Article
  12 May 2020 | Open Access

  Co-delivery of Doxorubicin and Curcumin with Polypeptide Nanocarrier for Synergistic Lymphoma Therapy

  • Wei Guo
  • , Yuanyuan Song
  •  & Ou Bai

• Article
  08 May 2020 | Open Access

  Predicting worse survival for newly diagnosed T cell lymphoma based on the decreased baseline CD16−/CD16 + monocyte ratio

  • Wei Zhang
  • , Jing Ruan
  •  & Mingqi Ouyang

• Article
  31 March 2020 | Open Access

  Narciclasine, an isocarbostyril alkaloid, has preferential activity against primary effusion lymphoma

  • Ramakrishnan Gopalakrishnan
  • , Hittu Matta
  •  & Preet M. Chaudhary

• Article
  09 March 2020 | Open Access

  A Clinico-Genotypic Prognostic Index for De Novo Composite Diffuse Large B-Cell Lymphoma Arising from Follicular Lymphoma in Asian patients treated in the Rituximab Era

  • Ryan Mao Heng Lim
  • , Natalie Pei Xin Chan
  •  & Jason Yongsheng Chan

• Article
  09 March 2020 | Open Access

  Dasatinib exacerbates splenomegaly of mice inoculated with Epstein-Barr virus-infected lymphoblastoid cell lines

  • Ryutaro Kotaki
  • , Masaharu Kawashima
  •  & Ai Kotani

• Article
  26 February 2020 | Open Access

  Type 2 diabetes mellitus compromises the survival of diffuse large B-cell lymphoma patients treated with (R)-CHOP – the PLRG report

  • Joanna Drozd-Sokolowska
  • , Jan Maciej Zaucha
  •  & Wojciech Jurczak

• Article
  13 February 2020 | Open Access

  SLAM family member 8 is expressed in and enhances the growth of anaplastic large cell lymphoma

  • Akihiko Sugimoto
  • , Tatsuki R. Kataoka
  •  & Hironori Haga

• Article
  17 January 2020 | Open Access

  The relationship between consumption of nitrite or nitrate and risk of non-Hodgkin lymphoma

  • Mengxia Yu
  • , Chenying Li
  •  & Jie Jin

• Article
  30 December 2019 | Open Access

  Pralatrexate in patients with recurrent or refractory peripheral T-cell lymphomas: a multicenter retrospective analysis

  • Jung Yong Hong
  • , Dok Hyun Yoon
  •  & Cheolwon Suh

• Article
  20 November 2019 | Open Access

  Identification of Circulating Serum Multi-MicroRNA Signatures in Human DLBCL Models

  • Afshin Beheshti
  • , Kristen Stevenson
  •  & Andrew M. Evens

• Article
  18 October 2019 | Open Access

  A clinicohaematological prognostic model for nasal-type natural killer/T-cell lymphoma: A multicenter study

  • Khee Ming Tan
  • , Burton Chia
  •  & Jason Yongsheng Chan

• Article
  10 October 2019 | Open Access

  Pro-oncogenic, intra host viral quasispecies in Diffuse large B cell lymphoma patients with occult Hepatitis B Virus infection

  • Mahua Sinha
  • , Keerthana Sundar
  •  & R. S. Jayshree

• Article
  10 October 2019 | Open Access

  Simulated microgravity-mediated reversion of murine lymphoma immune evasion

  • Jillian H. Bradley
  • , Shannon Barwick
  •  & Randal K. Gregg

• Article
  19 September 2019 | Open Access

  Cytarabine-based induction immunochemotherapy in the front-line treatment of older patients with mantle cell lymphoma

  • Sumita Ratnasingam
  • , Joshua Casan
  •  & Stephen Opat

• Article
  06 September 2019 | Open Access

  Classification of aggressive and classic mantle cell lymphomas using synchrotron Fourier Transform Infrared microspectroscopy

  • Magdalena Kolodziej
  • , Dorota Jesionek-Kupnicka
  •  & Izabela Zawlik

• Article
  21 August 2019 | Open Access

  Development of a Reproducible Prognostic Gene Signature to Predict the Clinical Outcome in Patients with Diffuse Large B-Cell Lymphoma

  • Mohamad Zamani-Ahmadmahmudi
  •  & Seyed Mahdi Nassiri

• Article
  18 July 2019 | Open Access

  Systematic Review of Somatic Mutations in Splenic Marginal Zone Lymphoma

  • Carolina Jaramillo Oquendo
  • , Helen Parker
  •  & Jonathan C. Strefford

• Article
  08 July 2019 | Open Access

  Differentiation of single lymphoma primary cells and normal B-cells based on their adhesion to mesenchymal stromal cells in optical tweezers

  • Kamila Duś-Szachniewicz
  • , Sławomir Drobczyński
  •  & Grzegorz Rymkiewicz